Acrivon Therapeutics (ACRV) P/E (2023 - 2026)
Acrivon Therapeutics (ACRV) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM Acrivon Therapeutics (ACRV) P/E is -0.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Acrivon Therapeutics (ACRV)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.75 | -23.15% |
| 2025 | -0.97 | -54.88% |
| 2024 | -2.16 | -0.16% |
| 2023 | -2.16 | N/A |
Comparison Acrivon Therapeutics (ACRV) P/E with competitors
Acrivon Therapeutics (ACRV) P/E is -0.75.